Michigan Medicine, formerly the University of Michigan Health System, is the wholly owned academic medical center of the University of Michigan, in Ann Arbor.

During the past decade, University of Michigan Hospital conducted 56 clinical trials. In the 10-year time frame, 56 clinical trials started and 55 clinical trials were completed, i.e. on average, 98.2% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 26 clinical trials were completed. i.e. 123.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Michigan Hospital" #1 sponsor was "University of Michigan" with 53 trials, followed by "University of Michigan Rogel Cancer Center" with 15 trials sponsored, "National Cancer Institute (NCI)" with 11 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 5 trials sponsored and "Pfizer" with 5 trials sponsored. Other sponsors include 49 different institutions and companies that sponsored additional 49 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Michigan Hospital" #1 collaborator was "National Institutes of Health (NIH)" with 8 trials as a collaborator, "National Cancer Institute (NCI)" with 7 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 6 trials as a collaborator, "Medical University of South Carolina" with 4 trials as a collaborator and "Johns Hopkins University" with 3 trials as a collaborator. Other collaborators include 55 different institutions and companies that were collaborators in the rest 58 trials.

According to Clinical.Site data, the most researched conditions in "University of Michigan Hospital" are "Amyotrophic Lateral Sclerosis" (3 trials), "Chronic Heart Failure" (3 trials), "Heart Failure" (3 trials), "Prostate Cancer" (3 trials) and "Acute Myeloid Leukemia" (2 trials). Many other conditions were trialed in "University of Michigan Hospital" in a lesser frequency.

Most popular intervention types in "University of Michigan Hospital" are "Drug" (73 trials), "Device" (28 trials), "Procedure" (28 trials), "Other" (20 trials) and "Biological" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "laboratory biomarker analysis" (5 trials), "placebo" (5 trials), "Carboplatin" (4 trials) and "Cisplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "University of Michigan Hospital" are 129 trials for "All" genders, 8 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "University of Michigan Hospital". undefined are not yet recruiting, 17 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 80 completed trials in University of Michigan Hospital, 1 suspended trials, and 23 terminated clinical trials to date.

Out of the total trials that were conducted in University of Michigan Hospital, 17 "Phase 1" clinical trials were conducted, 38 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 43 trials that are defined as “Not Applicable".